Federal rulemaking : improvements needed to monitoring and evaluation of rules development as well as to the transparency of OMB regulatory reviews : report to the Chairman, Committee on Oversight and Government Reform, House of Representatives.

Regulation is one of the principal tools that the government uses to implement public policy. As part of the rulemaking process federal agencies must comply with an increasing number of procedural and analytical requirements. GAO was asked to examine how broadly applicable rulemaking requiremen...

Full description

Bibliographic Details
Corporate Authors:	United States. Government Accountability Office, ProQuest (Firm), United States. Congress. House. Committee on Oversight and Government Reform
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : U.S. Govt. Accountability Office, [2009]
Series:	U.S. Congressional Research.
Subjects:	United States. > Environmental Protection Agency > Rules and practice. United States. > Food and Drug Administration > Rules and practice. United States. > Securities and Exchange Commission > Rules and practice. United States. > Office of Management and Budget. > Office of Information and Regulatory Affairs > Rules and practice. Administrative procedure > United States. Administrative regulation drafting > United States. Electronic books.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Regulation is one of the principal tools that the government uses to implement public policy. As part of the rulemaking process federal agencies must comply with an increasing number of procedural and analytical requirements. GAO was asked to examine how broadly applicable rulemaking requirements cumulatively have affected (1) agencies' rulemaking processes, in particular including effects of requirements added to the process since 2003, and (2) transparency of the Office of Information and Regulatory Affairs (OIRA) regulatory review process. To address these objectives, GAO reviewed selected rules issued between January 2006 and May 2008 and associated dockets and also interviewed knowledgeable agency and OIRA officials. GAO recommends that, consistent with internal control standards, the Environmental Protection Agency (EPA), Food and Drug Administration (FDA), and Securities and Exchange Commission (SEC) track and evaluate actual performance versus targeted milestones for developing significant rules to identify process improvement opportunities. GAO also recommends that OMB should provide additional guidance to agencies to improve transparency and documentation of the OIRA review process.
Item Description:	Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection. Reuse except for individual research requires license from ProQuest, LLC. Electronic resource.
Physical Description:	1 online resource.
Bibliography:	Includes bibliographical references.